Nonetheless, this postulation has been recently challenged by a report of inhibition of FMS-Like Tyrosine Kinase 3-Internal Tandem Duplication (FLT3-ITD) in resistant acute myeloid leukemia (AML) cells (17). This evidence concerns the gene FLT3 and acute myeloid leukemia.